LayerRx Mapping ID
268
Slot System
Featured Buckets
Featured Buckets Admin

How should we advise patients about the contraceptive patch, given the FDA warning?

Article Type
Changed
Mon, 07/23/2018 - 08:08
Display Headline
How should we advise patients about the contraceptive patch, given the FDA warning?
Article PDF
Author and Disclosure Information

Holly L. Thacker, MD
Director, Women’s Health Center at The Gault Women’s Health and Breast Pavilion, Department of General Internal Medicine, Department of Obstetrics and Gynecology, The Cleveland Clinic Foundation; Associate Professor of Medicine, Cleveland Clinic Lerner College of Medicine of Case-Western Reserve University

Tommaso Falcone, MD
Chairman, Department of Obstetrics and Gynecology, The Cleveland Clinic Foundation; Professor of Medicine, Cleveland Clinic Lerner College of Medicine of Case-Western Reserve University

Ashish Atreja, MD, MPH
Associate Program Director, Medical Informatics Fellowship, Department of General Internal Medicine, The Cleveland Clinic Foundation

Anil Jain, MD
Department of General Internal Medicine, The Cleveland Clinic Foundation

C. Martin Harris, MD, MBA
Chief Information Officer, Chairman, Information Technology Division, Department of Internal Medicine, The Cleveland Clinic Foundation

Address: Holly L. Thacker, MD, Gault Women’s Health and Breast Pavilion, A10, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Issue
Cleveland Clinic Journal of Medicine - 73(1)
Publications
Topics
Page Number
45-47
Sections
Author and Disclosure Information

Holly L. Thacker, MD
Director, Women’s Health Center at The Gault Women’s Health and Breast Pavilion, Department of General Internal Medicine, Department of Obstetrics and Gynecology, The Cleveland Clinic Foundation; Associate Professor of Medicine, Cleveland Clinic Lerner College of Medicine of Case-Western Reserve University

Tommaso Falcone, MD
Chairman, Department of Obstetrics and Gynecology, The Cleveland Clinic Foundation; Professor of Medicine, Cleveland Clinic Lerner College of Medicine of Case-Western Reserve University

Ashish Atreja, MD, MPH
Associate Program Director, Medical Informatics Fellowship, Department of General Internal Medicine, The Cleveland Clinic Foundation

Anil Jain, MD
Department of General Internal Medicine, The Cleveland Clinic Foundation

C. Martin Harris, MD, MBA
Chief Information Officer, Chairman, Information Technology Division, Department of Internal Medicine, The Cleveland Clinic Foundation

Address: Holly L. Thacker, MD, Gault Women’s Health and Breast Pavilion, A10, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Author and Disclosure Information

Holly L. Thacker, MD
Director, Women’s Health Center at The Gault Women’s Health and Breast Pavilion, Department of General Internal Medicine, Department of Obstetrics and Gynecology, The Cleveland Clinic Foundation; Associate Professor of Medicine, Cleveland Clinic Lerner College of Medicine of Case-Western Reserve University

Tommaso Falcone, MD
Chairman, Department of Obstetrics and Gynecology, The Cleveland Clinic Foundation; Professor of Medicine, Cleveland Clinic Lerner College of Medicine of Case-Western Reserve University

Ashish Atreja, MD, MPH
Associate Program Director, Medical Informatics Fellowship, Department of General Internal Medicine, The Cleveland Clinic Foundation

Anil Jain, MD
Department of General Internal Medicine, The Cleveland Clinic Foundation

C. Martin Harris, MD, MBA
Chief Information Officer, Chairman, Information Technology Division, Department of Internal Medicine, The Cleveland Clinic Foundation

Address: Holly L. Thacker, MD, Gault Women’s Health and Breast Pavilion, A10, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 73(1)
Issue
Cleveland Clinic Journal of Medicine - 73(1)
Page Number
45-47
Page Number
45-47
Publications
Publications
Topics
Article Type
Display Headline
How should we advise patients about the contraceptive patch, given the FDA warning?
Display Headline
How should we advise patients about the contraceptive patch, given the FDA warning?
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Renovascular hypertension: Balancing the controversies in diagnosis and treatment

Article Type
Changed
Wed, 09/12/2018 - 12:19
Display Headline
Renovascular hypertension: Balancing the controversies in diagnosis and treatment
Article PDF
Author and Disclosure Information

Vesna D. Garovic, MD
Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic College of Medicine, Rochester, MN

Garvan C. Kane, MB, BCh
Division of Cardiovascular Diseases, Department of Medicine, Mayo Clinic College of Medicine, Rochester, MN

Gary L. Schwartz, MD
Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic College of Medicine, Rochester, MN

Address: Vesna D. Garovic, MD, Division of Nephrology and Hypertension, Mayo Clinic, 200 First Street SW, Rochester, MN 55905; email [email protected]

Issue
Cleveland Clinic Journal of Medicine - 72(12)
Publications
Topics
Page Number
1135-1144, 1146-1147
Sections
Author and Disclosure Information

Vesna D. Garovic, MD
Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic College of Medicine, Rochester, MN

Garvan C. Kane, MB, BCh
Division of Cardiovascular Diseases, Department of Medicine, Mayo Clinic College of Medicine, Rochester, MN

Gary L. Schwartz, MD
Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic College of Medicine, Rochester, MN

Address: Vesna D. Garovic, MD, Division of Nephrology and Hypertension, Mayo Clinic, 200 First Street SW, Rochester, MN 55905; email [email protected]

Author and Disclosure Information

Vesna D. Garovic, MD
Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic College of Medicine, Rochester, MN

Garvan C. Kane, MB, BCh
Division of Cardiovascular Diseases, Department of Medicine, Mayo Clinic College of Medicine, Rochester, MN

Gary L. Schwartz, MD
Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic College of Medicine, Rochester, MN

Address: Vesna D. Garovic, MD, Division of Nephrology and Hypertension, Mayo Clinic, 200 First Street SW, Rochester, MN 55905; email [email protected]

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 72(12)
Issue
Cleveland Clinic Journal of Medicine - 72(12)
Page Number
1135-1144, 1146-1147
Page Number
1135-1144, 1146-1147
Publications
Publications
Topics
Article Type
Display Headline
Renovascular hypertension: Balancing the controversies in diagnosis and treatment
Display Headline
Renovascular hypertension: Balancing the controversies in diagnosis and treatment
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Use of corticosteroids in the sepsis syndrome: What do we know now?

Article Type
Changed
Wed, 09/12/2018 - 11:07
Display Headline
Use of corticosteroids in the sepsis syndrome: What do we know now?
Article PDF
Author and Disclosure Information

Steven P. LaRosa, MD
Director, Ocean State Clinical Coordinating Center; Attending Physician, Division of Infectious Disease, Rhode Island Hospital; Assistant Professor of Medicine, Brown Medical School, Providence, RI

Address: Steven LaRosa, MD, Rhode Island Hospital, Gerry House 113, 593 Eddy Street, Providence, RI 02903; e-mail [email protected]

Issue
Cleveland Clinic Journal of Medicine - 72(12)
Publications
Topics
Page Number
1121-1127
Sections
Author and Disclosure Information

Steven P. LaRosa, MD
Director, Ocean State Clinical Coordinating Center; Attending Physician, Division of Infectious Disease, Rhode Island Hospital; Assistant Professor of Medicine, Brown Medical School, Providence, RI

Address: Steven LaRosa, MD, Rhode Island Hospital, Gerry House 113, 593 Eddy Street, Providence, RI 02903; e-mail [email protected]

Author and Disclosure Information

Steven P. LaRosa, MD
Director, Ocean State Clinical Coordinating Center; Attending Physician, Division of Infectious Disease, Rhode Island Hospital; Assistant Professor of Medicine, Brown Medical School, Providence, RI

Address: Steven LaRosa, MD, Rhode Island Hospital, Gerry House 113, 593 Eddy Street, Providence, RI 02903; e-mail [email protected]

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 72(12)
Issue
Cleveland Clinic Journal of Medicine - 72(12)
Page Number
1121-1127
Page Number
1121-1127
Publications
Publications
Topics
Article Type
Display Headline
Use of corticosteroids in the sepsis syndrome: What do we know now?
Display Headline
Use of corticosteroids in the sepsis syndrome: What do we know now?
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Dyslipidemia in HIV patients

Article Type
Changed
Wed, 09/12/2018 - 11:05
Display Headline
Dyslipidemia in HIV patients
Article PDF
Author and Disclosure Information

Marisa Tungsiripat, MD
Department of Infectious Diseases, The Cleveland Clinic Foundation

Judith A. Aberg, MD
Associate Professor of Medicine, Director of HIV, Bellevue Hospital Center, Director of AIDS Clinical Trials Unit, New York University

Address: Marisa Tungsiripat, MD, Department of Infectious Diseases, S32, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

Dr. Aberg has indicated that she is a consultant for Bristol-Myers Squibb, Boehringer-Ingelheim, Gilead Sciences, and Glaxo-SmithKline. She received research support from Bristol-Myers Squibb, Abbott, and Merck and is active in the leadership for the National Institute of Allergy and Infectious Diseases-sponsored AIDS Clinical Trials Group.

Issue
Cleveland Clinic Journal of Medicine - 72(12)
Publications
Topics
Page Number
1113-1120
Sections
Author and Disclosure Information

Marisa Tungsiripat, MD
Department of Infectious Diseases, The Cleveland Clinic Foundation

Judith A. Aberg, MD
Associate Professor of Medicine, Director of HIV, Bellevue Hospital Center, Director of AIDS Clinical Trials Unit, New York University

Address: Marisa Tungsiripat, MD, Department of Infectious Diseases, S32, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

Dr. Aberg has indicated that she is a consultant for Bristol-Myers Squibb, Boehringer-Ingelheim, Gilead Sciences, and Glaxo-SmithKline. She received research support from Bristol-Myers Squibb, Abbott, and Merck and is active in the leadership for the National Institute of Allergy and Infectious Diseases-sponsored AIDS Clinical Trials Group.

Author and Disclosure Information

Marisa Tungsiripat, MD
Department of Infectious Diseases, The Cleveland Clinic Foundation

Judith A. Aberg, MD
Associate Professor of Medicine, Director of HIV, Bellevue Hospital Center, Director of AIDS Clinical Trials Unit, New York University

Address: Marisa Tungsiripat, MD, Department of Infectious Diseases, S32, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

Dr. Aberg has indicated that she is a consultant for Bristol-Myers Squibb, Boehringer-Ingelheim, Gilead Sciences, and Glaxo-SmithKline. She received research support from Bristol-Myers Squibb, Abbott, and Merck and is active in the leadership for the National Institute of Allergy and Infectious Diseases-sponsored AIDS Clinical Trials Group.

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 72(12)
Issue
Cleveland Clinic Journal of Medicine - 72(12)
Page Number
1113-1120
Page Number
1113-1120
Publications
Publications
Topics
Article Type
Display Headline
Dyslipidemia in HIV patients
Display Headline
Dyslipidemia in HIV patients
Sections
Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Primary hyperparathyroidism: 7,000 years of progress

Article Type
Changed
Wed, 09/12/2018 - 09:54
Display Headline
Primary hyperparathyroidism: 7,000 years of progress
Article PDF
Author and Disclosure Information

Michael A. Levine, MD
Chairman, Division of Pediatrics, The Cleveland Clinic Foundation

Address: Michael A. Levine, MD, Department of Pediatric Endocrinology, S25, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Medical Grand Rounds articles are based on edited transcripts from Heart Center Grand Rounds presentations at The Cleveland Clinic Foundation. They are approved by the author but are not peer-reviewed.

Issue
Cleveland Clinic Journal of Medicine - 72(12)
Publications
Topics
Page Number
1084-1085, 1088, 1091-1092, 1095-1098
Sections
Author and Disclosure Information

Michael A. Levine, MD
Chairman, Division of Pediatrics, The Cleveland Clinic Foundation

Address: Michael A. Levine, MD, Department of Pediatric Endocrinology, S25, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Medical Grand Rounds articles are based on edited transcripts from Heart Center Grand Rounds presentations at The Cleveland Clinic Foundation. They are approved by the author but are not peer-reviewed.

Author and Disclosure Information

Michael A. Levine, MD
Chairman, Division of Pediatrics, The Cleveland Clinic Foundation

Address: Michael A. Levine, MD, Department of Pediatric Endocrinology, S25, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Medical Grand Rounds articles are based on edited transcripts from Heart Center Grand Rounds presentations at The Cleveland Clinic Foundation. They are approved by the author but are not peer-reviewed.

Article PDF
Article PDF
Related Articles
Issue
Cleveland Clinic Journal of Medicine - 72(12)
Issue
Cleveland Clinic Journal of Medicine - 72(12)
Page Number
1084-1085, 1088, 1091-1092, 1095-1098
Page Number
1084-1085, 1088, 1091-1092, 1095-1098
Publications
Publications
Topics
Article Type
Display Headline
Primary hyperparathyroidism: 7,000 years of progress
Display Headline
Primary hyperparathyroidism: 7,000 years of progress
Sections
Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

How long can my patient use intranasal steroid sprays?

Article Type
Changed
Wed, 09/12/2018 - 09:47
Display Headline
How long can my patient use intranasal steroid sprays?
Article PDF
Author and Disclosure Information

Lily C. Pien, MD
Department of Pulmonary, Allergy, and Critical Care Medicine, The Cleveland Clinic Foundation

Address: Lily C. Pien, MD, Department of Pulmonary, Allergy, and Critical Care Medicine, C22, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

Issue
Cleveland Clinic Journal of Medicine - 72(12)
Publications
Topics
Page Number
1079-1080, 1082
Sections
Author and Disclosure Information

Lily C. Pien, MD
Department of Pulmonary, Allergy, and Critical Care Medicine, The Cleveland Clinic Foundation

Address: Lily C. Pien, MD, Department of Pulmonary, Allergy, and Critical Care Medicine, C22, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

Author and Disclosure Information

Lily C. Pien, MD
Department of Pulmonary, Allergy, and Critical Care Medicine, The Cleveland Clinic Foundation

Address: Lily C. Pien, MD, Department of Pulmonary, Allergy, and Critical Care Medicine, C22, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 72(12)
Issue
Cleveland Clinic Journal of Medicine - 72(12)
Page Number
1079-1080, 1082
Page Number
1079-1080, 1082
Publications
Publications
Topics
Article Type
Display Headline
How long can my patient use intranasal steroid sprays?
Display Headline
How long can my patient use intranasal steroid sprays?
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

What is a 'failure' of bisphosphonate therapy for osteoporosis?

Article Type
Changed
Wed, 09/12/2018 - 08:53
Display Headline
What is a 'failure' of bisphosphonate therapy for osteoporosis?
Article PDF
Author and Disclosure Information

John J. Carey, MD
Department of Rheumatic and Immunologic Diseases, The Cleveland Clinic Foundation

Address: John J. Carey, MD, Department of Rheumatic and Immunologic Diseases, A50, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Dr. Carey has indicated that he has received grant or research support from the Proctor and Gamble corporation, serves as a consultant for Eli Lilly and Company, and is on the speaker’s bureau of Proctor and Gamble.

Issue
Cleveland Clinic Journal of Medicine - 72(11)
Publications
Topics
Page Number
1033-1039
Sections
Author and Disclosure Information

John J. Carey, MD
Department of Rheumatic and Immunologic Diseases, The Cleveland Clinic Foundation

Address: John J. Carey, MD, Department of Rheumatic and Immunologic Diseases, A50, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Dr. Carey has indicated that he has received grant or research support from the Proctor and Gamble corporation, serves as a consultant for Eli Lilly and Company, and is on the speaker’s bureau of Proctor and Gamble.

Author and Disclosure Information

John J. Carey, MD
Department of Rheumatic and Immunologic Diseases, The Cleveland Clinic Foundation

Address: John J. Carey, MD, Department of Rheumatic and Immunologic Diseases, A50, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Dr. Carey has indicated that he has received grant or research support from the Proctor and Gamble corporation, serves as a consultant for Eli Lilly and Company, and is on the speaker’s bureau of Proctor and Gamble.

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 72(11)
Issue
Cleveland Clinic Journal of Medicine - 72(11)
Page Number
1033-1039
Page Number
1033-1039
Publications
Publications
Topics
Article Type
Display Headline
What is a 'failure' of bisphosphonate therapy for osteoporosis?
Display Headline
What is a 'failure' of bisphosphonate therapy for osteoporosis?
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Anemia in chronic heart failure: Can EPO reduce deaths?

Article Type
Changed
Wed, 09/12/2018 - 08:49
Display Headline
Anemia in chronic heart failure: Can EPO reduce deaths?
Article PDF
Author and Disclosure Information

Srinivas Iyengar, MD
Division of Cardiovascular Medicine, The Ohio State University, Columbus

William T. Abraham, MD
Professor of Medicine and Chief, Division of Cardiovascular Medicine, The Ohio State University, Columbus

Address: Srinivas Iyengar, MD, Division of Cardiovascular Medicine, The Ohio State University, 473 West 12th Avenue, Room 110P DHLRI, Columbus, OH 43210-1252; e-mail [email protected]

Issue
Cleveland Clinic Journal of Medicine - 72(11)
Publications
Topics
Page Number
1027-1032
Sections
Author and Disclosure Information

Srinivas Iyengar, MD
Division of Cardiovascular Medicine, The Ohio State University, Columbus

William T. Abraham, MD
Professor of Medicine and Chief, Division of Cardiovascular Medicine, The Ohio State University, Columbus

Address: Srinivas Iyengar, MD, Division of Cardiovascular Medicine, The Ohio State University, 473 West 12th Avenue, Room 110P DHLRI, Columbus, OH 43210-1252; e-mail [email protected]

Author and Disclosure Information

Srinivas Iyengar, MD
Division of Cardiovascular Medicine, The Ohio State University, Columbus

William T. Abraham, MD
Professor of Medicine and Chief, Division of Cardiovascular Medicine, The Ohio State University, Columbus

Address: Srinivas Iyengar, MD, Division of Cardiovascular Medicine, The Ohio State University, 473 West 12th Avenue, Room 110P DHLRI, Columbus, OH 43210-1252; e-mail [email protected]

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 72(11)
Issue
Cleveland Clinic Journal of Medicine - 72(11)
Page Number
1027-1032
Page Number
1027-1032
Publications
Publications
Topics
Article Type
Display Headline
Anemia in chronic heart failure: Can EPO reduce deaths?
Display Headline
Anemia in chronic heart failure: Can EPO reduce deaths?
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Safety of statins: Effects on muscle and the liver

Article Type
Changed
Wed, 09/12/2018 - 08:39
Display Headline
Safety of statins: Effects on muscle and the liver
Article PDF
Author and Disclosure Information

Abu R. Vasudevan, MBBS, MD, MRCP
Clinical Instructor, Division of Endocrinology and Metabolism, Center for Cardiovascular Disease Prevention, Lipid and Atherosclerosis Section, Department of Medicine, Baylor College of Medicine, Houston, TX

Yasmin S. Hamirani, MBBS
Lipid and Atherosclerosis Section, Department of Medicine, Baylor College of Medicine, Houston, TX

Peter H. Jones, MD
Associate Professor, Lipid and Atherosclerosis Section, Department of Medicine, Baylor College of Medicine, Houston, TX

Address: Peter H. Jones, MD, Lipid and Atherosclerosis Section, Department of Medicine, Baylor College of Medicine, 6565 Fannin, Suite B160, Mail stop A601, Houston, TX 77030; e-mail [email protected]

Dr. Jones has indicated that he has received grant or research support from the Abbott, AstraZeneca, KOS, and Pfizer corporations.

Issue
Cleveland Clinic Journal of Medicine - 72(11)
Publications
Topics
Page Number
990-993, 996-1001
Sections
Author and Disclosure Information

Abu R. Vasudevan, MBBS, MD, MRCP
Clinical Instructor, Division of Endocrinology and Metabolism, Center for Cardiovascular Disease Prevention, Lipid and Atherosclerosis Section, Department of Medicine, Baylor College of Medicine, Houston, TX

Yasmin S. Hamirani, MBBS
Lipid and Atherosclerosis Section, Department of Medicine, Baylor College of Medicine, Houston, TX

Peter H. Jones, MD
Associate Professor, Lipid and Atherosclerosis Section, Department of Medicine, Baylor College of Medicine, Houston, TX

Address: Peter H. Jones, MD, Lipid and Atherosclerosis Section, Department of Medicine, Baylor College of Medicine, 6565 Fannin, Suite B160, Mail stop A601, Houston, TX 77030; e-mail [email protected]

Dr. Jones has indicated that he has received grant or research support from the Abbott, AstraZeneca, KOS, and Pfizer corporations.

Author and Disclosure Information

Abu R. Vasudevan, MBBS, MD, MRCP
Clinical Instructor, Division of Endocrinology and Metabolism, Center for Cardiovascular Disease Prevention, Lipid and Atherosclerosis Section, Department of Medicine, Baylor College of Medicine, Houston, TX

Yasmin S. Hamirani, MBBS
Lipid and Atherosclerosis Section, Department of Medicine, Baylor College of Medicine, Houston, TX

Peter H. Jones, MD
Associate Professor, Lipid and Atherosclerosis Section, Department of Medicine, Baylor College of Medicine, Houston, TX

Address: Peter H. Jones, MD, Lipid and Atherosclerosis Section, Department of Medicine, Baylor College of Medicine, 6565 Fannin, Suite B160, Mail stop A601, Houston, TX 77030; e-mail [email protected]

Dr. Jones has indicated that he has received grant or research support from the Abbott, AstraZeneca, KOS, and Pfizer corporations.

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 72(11)
Issue
Cleveland Clinic Journal of Medicine - 72(11)
Page Number
990-993, 996-1001
Page Number
990-993, 996-1001
Publications
Publications
Topics
Article Type
Display Headline
Safety of statins: Effects on muscle and the liver
Display Headline
Safety of statins: Effects on muscle and the liver
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

DHEA supplementation: The claims in perspective

Article Type
Changed
Tue, 05/03/2022 - 16:09
Display Headline
DHEA supplementation: The claims in perspective
Article PDF
Author and Disclosure Information

Ewa Olech, MD
Clinical Pharmacology Research Program,Oklahoma Medical Research Foundation; Clinical Assistant Professor, University of Oklahoma Health Sciences Center, Oklahoma City

Joan T. Merrill, MD
Head, Clinical Pharmacology Research Program, Oklahoma Medical Research Foundation, and Professor of Medicine, Oklahoma Health Sciences Center, Oklahoma City; Medical Director, Lupus Foundation of America

Address: Joan T. Merrill, MD, Oklahoma Medical Research Foundation, 825 Northeast 13th Street, Oklahoma City, OK 73104

Dr. Merrill has indicated that she is a consultant for Genelabs and has received grant or research support from Genelabs.

Issue
Cleveland Clinic Journal of Medicine - 72(11)
Publications
Topics
Page Number
965-966, 968, 970-971, 975-977, 983-984
Sections
Author and Disclosure Information

Ewa Olech, MD
Clinical Pharmacology Research Program,Oklahoma Medical Research Foundation; Clinical Assistant Professor, University of Oklahoma Health Sciences Center, Oklahoma City

Joan T. Merrill, MD
Head, Clinical Pharmacology Research Program, Oklahoma Medical Research Foundation, and Professor of Medicine, Oklahoma Health Sciences Center, Oklahoma City; Medical Director, Lupus Foundation of America

Address: Joan T. Merrill, MD, Oklahoma Medical Research Foundation, 825 Northeast 13th Street, Oklahoma City, OK 73104

Dr. Merrill has indicated that she is a consultant for Genelabs and has received grant or research support from Genelabs.

Author and Disclosure Information

Ewa Olech, MD
Clinical Pharmacology Research Program,Oklahoma Medical Research Foundation; Clinical Assistant Professor, University of Oklahoma Health Sciences Center, Oklahoma City

Joan T. Merrill, MD
Head, Clinical Pharmacology Research Program, Oklahoma Medical Research Foundation, and Professor of Medicine, Oklahoma Health Sciences Center, Oklahoma City; Medical Director, Lupus Foundation of America

Address: Joan T. Merrill, MD, Oklahoma Medical Research Foundation, 825 Northeast 13th Street, Oklahoma City, OK 73104

Dr. Merrill has indicated that she is a consultant for Genelabs and has received grant or research support from Genelabs.

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 72(11)
Issue
Cleveland Clinic Journal of Medicine - 72(11)
Page Number
965-966, 968, 970-971, 975-977, 983-984
Page Number
965-966, 968, 970-971, 975-977, 983-984
Publications
Publications
Topics
Article Type
Display Headline
DHEA supplementation: The claims in perspective
Display Headline
DHEA supplementation: The claims in perspective
Sections
Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media